Hormetic priming creates an epigenetic memory that sustains FOXO3‑driven autophagy, lowering senescent cell formation and mimicking senolytic durability

Core idea Repeated mild stressors (heat, exercise, intermittent fasting) do not merely provoke a transient threat response; they install a stable chromatin state at promoters of FOXO3‑target autophagy genes. This epigenetic memory keeps the proteostatic machinery heightened long after the stressor ends, thereby decreasing the generation of new senescent cells. In contrast, senolytics eliminate existing senescent cells but do not alter the rate at which new ones arise. The hypothesis predicts that the longevity benefit of hormesis depends on this epigenetically maintained autophagy program, and that erasing the memory will abolish the durable reduction in senescent cell burden while leaving the acute stress response intact.

Mechanistic reasoning

1. Hormetic stimuli activate NAD⁺‑dependent deacetylases (SIRT1) and AMPK, which phosphorylate FOXO3, promoting its nuclear translocation and transcription of LC3, BECN1, and SQSTM1.
2. Concurrently, stress‑induced MAPK signaling recruits histone acetyltransferases (p300/CBP) to FOXO3‑bound enhancers, depositing H3K27ac marks that persist through cell divisions.
3. These acetylated nucleosomes recruit bromodomain proteins (BRD4) that maintain transcriptional openness, creating a self‑reinforcing loop: sustained FOXO3 activity → autophagy → reduced oxidative damage → less SASP → lower paracrine senescence induction.
4. Senolytics (dasatinib+quercetin) act downstream by dis

Hypothesis

We hypothesize that baseline pressure pain sensitivity (lower threshold) predicts accelerated epigenetic aging over a 2‑year follow‑up, and that this relationship is mediated by age‑related decline in Leydig cell testosterone production driven by mitochondrial dysfunction and reduced StAR‑mediated cholesterol flux.

Mechanistic Rationale

1. Pain sensitivity reflects the efficacy of descending pain modulatory systems, which depend on opioid and non‑opioid tone that is upregulated by testosterone.[5][6]
2. Testosterone synthesis in Leydig cells requires cholesterol transport into mitochondria via the StAR protein; mitochondrial oxidative phosphorylation fuels this step.[9]
3. With aging, Leydig cell mitochondria accumulate damage, limiting ATP and increasing ROS, which diminishes StAR activity and testosterone output.[10]
4. Lower testosterone reduces central analgesic tone, lowering pain thresholds and increasing perceived sensitivity.
5. Simultaneously, diminished steroid signaling lifts inhibition on NF‑κB pathways, fostering low‑grade inflammation that drives epigenetic aging clocks (DNAmPhenoAge, DNAmGrimAge).[1][2]

Thus, pain sensitivity is a functional read‑out of Leydig cell mitochondrial health and steroidogenic capacity, linking perception to systemic biological age.

Testable Predictions

Hypothesis

Aging of the colonic epithelium is driven not by intrinsic DNA damage but by epigenetically reprogrammed myeloid cells that deposit pro‑inflammatory methylation marks on neighboring epithelial stem cells, accelerating their epigenetic clock before any measurable telomere loss or mutation load.

Mechanistic Rationale

Recent work shows that hematopoietic aging independently fuels tumor progression via emergency myelopoiesis and accumulation of myeloid progenitor‑like cells in neoplasms [1]. In the aged colon, myeloid‑derived suppressor cells (MDSCs) and M2‑like tumor‑associated macrophages increase, secreting TNF‑α, IL‑6, and ROS that alter DNA methyltransferase activity in adjacent epithelium [4][5]. It's known that these cytokines upregulate DNMT3B and downregulate TET2, leading to hypermethylation at promoters of tumor suppressor genes and hypomethylation at inflammatory loci, mirroring the 15 aging‑linked CpG sites linked to colorectal cancer risk [6].

We propose that this immune‑derived methyltransferase flux creates a spatial gradient of epigenetic age: crypts closest to infiltrating myeloid clusters exhibit advanced Horvath‑like methylation signatures, while distal crypts retain younger profiles. This gradient precedes detectable changes in epithelial proliferation or barrier loss, positioning immune methylation as the primary driver.

Predictions and Experimental Design

1. Spatial methyl‑age mapping – Perform laser‑capture microdissection of colonic crypts from young (20‑30 y) and old (70‑80 y) donors, isolate epithelial cells adjacent to C

Hypothesis: Immune TFEB Reprogramming as a Primary Lever to Delay Systemic Aging

Core idea – Restoring TFEB activity specifically in hematopoietic cells will suppress inflammaging, improve organelle clearance, and extend healthspan without requiring broader systemic interventions.

Rationale

Aging is marked by a decline in autophagy gene expression (ATG5, ATG7, ATG12) driven by impaired TFEB nuclear translocation (1). This defect is especially pronounced in immune cells, where defective mitophagy fuels mitochondrial ROS, inflammasome activation, and a senescence‑associated secretory phenotype (SASP) rich in IL‑6 and IL‑1β (2). The resulting inflammaging propagates tissue damage, creating a vicious loop that accelerates functional decline across organs.

Evidence shows that macrophage‑specific TFEB overexpression attenuates atherosclerosis (3), while TFEB loss in kidney proximal tubules triggers systemic metabolic disturbance and amyloidosis (4). These tissue‑restricted manipulations demonstrate that immune TFEB can influence organism‑wide phenotypes, yet no study has tested whether immune‑centric TFEB rescue alone is sufficient to reverse global aging markers.

Novel mechanistic extension

Beyond autophagy, TFEB directly regulates the expression of immunoproteasome subunits (PSMB8, PSMB9, PSMB10) and lysosomal enzymes that process MHC‑I peptide loading. In senescen

Hypothesis

Senescent immune cells actively release mitochondrial DNA (mtDNA) into the extracellular space, where it acts as a damage‑associated molecular pattern (DAMP) that triggers the cGAS‑STING pathway in stromal cells, leading to chronic type‑I interferon signaling and amplification of the senescence‑associated secretory phenotype (SASP). This mechanism positions mitochondrial DAMPs from the immune system as a primary driver of systemic aging, rather than a mere by‑product of immune decline.

Mechanistic Basis

1. mtDNA release – Senescent T cells and macrophages exhibit mitochondrial dysfunction and increased mitochondrial permeability, allowing mtDNA to escape into the cytosol and be packaged into extracellular vesicles (EVs) 2.
2. DAMP signaling – Extracellular mtDNA binds cytosolic cGAS in stromal fibroblasts and epithelial cells, activating STING‑dependent IRF3 phosphorylation and IFN‑β production 3.
3. SASP amplification – IFN‑β signaling induces STAT1‑mediated transcription of IL‑6, IL‑1β, and MMPs, creating a paracrine loop that reinforces immune cell senescence and tissue damage 4.
4. Feedback to hematopoietic stem cells – Chronic IFN exposure skews hematopoiesis toward myeloid lineages, further increasing the pool of senescent innate cells 5.

Thus, the immune system does not merely fail to clear senescent neighbors; it activel

Hypothesis

Aging germinal centers suffer a two‑hit defect: (1) intrinsic mitochondrial oxidative stress in B cells dampens activation‑induced cytidine deaminase (AID) expression, and (2) age‑associated B cells (ABCs) amplify this stress by secreting IFN‑γ and TNF‑α that further impair B‑cell mitochondrial function. Restricting mitochondrial ROS with a targeted antioxidant (e.g., MitoQ) combined with Btk‑mediated ABC depletion will rescue AID induction, restore somatic hypermutation, and improve vaccine‑elicited antibody affinity in aged hosts.

Mechanistic rationale

• Mitochondrial ROS as an AID gatekeeper – Recent work shows that AID transcription is sensitive to redox‑sensitive transcription factors (FoxO1, NF‑κB) that are inactivated by elevated H₂O₂. In aged B cells, declining mitophagy and increased electron‑transport leak raise mitochondrial ROS, leading to sustained FoxO1 nuclear exclusion and reduced AID promoter activity. This provides a cell‑intrinsic explanation for the observed 19 % versus 85 % fold‑increase in AID after vaccination in elderly versus young individuals [2].
• ABCs as ROS amplifiers – CD11c⁺ ABCs accumulate via chronic BCR signaling and secrete pro‑inflammatory cytokines (IFN‑γ, TNF‑α) that impair mitochondrial respiration in neighboring B cells via STAT1‑dependent up‑regulation of NADPH oxidases [3]. Thus, ABCs create a paracrine oxidative milieu that exacerbates the intrinsic ROS burden.
• Synergy with Tfh insufficiency – Reduced CD40L on aged Tfh limits CD40‑NF‑κB signaling, a pathway that normally up‑regulates antioxidant ge

Hypothesis

Telomere length sets the upper bound of transcriptional entropy by controlling the extent of heterochromatin‑mediated chromatin looping (TPE‑OLD). As telomeres shorten, loops dissolve, increasing the dimensionality of accessible gene‑expression states and raising transcriptional noise. This rise in entropy precedes functional decline and creates a permissive landscape for oncogenic transcriptional programs. Conversely, cancer cells reactivate telomerase or lengthen telomeres via ALT to collapse this entropy, re‑establishing a low‑noise chromatin configuration that locks in proliferative gene expression.

Mechanistic core

• Telomere‑associated heterochromatin forms liquid‑liquid phase‑separated domains that sequester distal genes. Long telomeres promote larger, more stable heterochromatin droplets, reducing chromatin mobility and transcriptional bursting.
• Short telomeres yield smaller, more dynamic droplets, increasing chromatin exploration and stochastic gene activation, measurable as increased single‑cell RNA‑seq variance (entropy).
• TERRA modulates droplet surface tension by competing for heterochromatin proteins (e.g., HP1, Ku), acting as a tunable surfactant that couples telomere length to droplet material properties.

Testable predictions

1. In isogenic human fibroblasts graded by telomere length (via CRISPR‑telomerase titration), single‑cell transcriptomic entropy (Shannon entropy of gene‑expression distributions) will rise monotonically with shortening, independent of proliferation rate.
2. Acute depletion of TERRA will increase heterochroma

Hypothesis

In aged cells, the upregulation of autophagy inhibitors such as Rubicon does not simply reflect a breakdown of cleanup machinery. Instead, it actively sequesters toxic protein aggregates into long‑lived, autophagy‑derived compartments that act as inert depots. By locking aggregates inside these vesicles, the cell prevents their release, templated seeding, and subsequent spread to neighboring cells or extracellular space. This suppression is therefore a protective trade‑off: tolerating intracellular storage avoids the greater danger of propagating proteopathic strains throughout tissue.

Mechanistic Rationale

• Aggregate sequestration: During aging, misfolded proteins (e.g., α‑synuclein, tau) are preferentially captured by nascent autophagosomes. Rubicon‑mediated inhibition of VPS34 stalls autophagosome maturation, converting these vesicles into stable, lysosome‑resistant storage bodies.
• Consequences of premature activation: Forced autophagic flux (via Rubicon knockdown or mTORC1 inhibition) would disrupt these depots, liberating aggregates that can act as seeds for further misfolding and trigger inflammasome activation through extracellular danger signals.
• Feedback to senescence: Persistent aggregate retention reduces cytosolic stress signaling, delaying the onset of senescence‑associated secretory phenotype (SASP). Conversely, acute aggregate release accelerates senescence, as shown by autophagy‑deficient cardiomyocytes adopting a senescent state [5].
• Tissue specificity: In adipocytes, de

Hypothesis

We propose that telomere length does not merely record past oxidative damage but actively modulates mitochondrial reactive oxygen species (ROS) output via a nuclear‑retrograde signaling pathway. Short telomeres trigger a chromatin state that up‑regulates mitochondrial ROS‑producing enzymes, thereby amplifying oxidative stress and it's creating a self‑reinforcing loop that accelerates senescence. Conversely, long telomeres suppress this signal, limiting ROS generation and preserving cellular function.

Mechanistic Basis

1. Telomere‑dependent chromatin remodeling – Telomere length influences the recruitment of histone modifiers (e.g., SUV39H1, HDACs) to subtelomeric regions, which can spread to nuclear genes encoding mitochondrial proteins such as NOX4 and CYBA (Oxidative stress accelerates telomere shortening).
2. Retrograde signaling – Altered expression of these mitochondrial proteins changes electron‑transport‑chain flux, increasing ROS leak. Mitochondrial ROS then feeds back to nucleus, further damaging telomeres (Telomere length reflects cumulative oxidative/inflammatory stress).
3. Feedback amplification – Because telomere shortening depends nearly quadratically on ROS levels, even modest increases in mitochondrial ROS produce disproportionate telomere attrition, locking the cell into a high‑ROS, short‑telomere state ([Telomere misconceptions blog](https://michaelfossel.com/blog/telomeres/telomere-misconception

Hypothesis

Age‑associated elevation of long cfDNA fragments (>175 bp) results from oxidative inhibition of the DNase1L3 nuclease, which impairs complete chromatin digestion during apoptosis and necrosis. The resulting persistently methylated DNA fragments act as endogenous TLR9 ligands, sustaining low‑grade inflammation and contributing to inflamm‑aging. Concurrently, age‑related hypermethylation of histone H1 variants loosens nucleosome packing, making chromatin more susceptible to incomplete cleavage and biasing the fragment pool toward larger sizes.

Mechanistic Basis

• Oxidative modification: Reactive oxygen species increase with age and can oxidize the catalytic histidine of DNase1L3, reducing its activity 1.
• Chromatin accessibility: Hypermethylation of histone H1 genes (e.g., H1F0, H1FX) decreases linker histone binding, producing more open chromatin that resists full nuclease digestion 1.
• Fragment signaling: Long cfDNA retains nucleosomal methylation patterns at CpG islands of inflammatory genes; when internalized by plasmacytoid dendritic cells, these fragments trigger TLR9‑dependent NF‑κB signaling, elevating MCP‑1 and IL‑6 1.

Predictions

1. Older individuals will show higher plasma levels of oxidized DNase1L3 (detected by carbonyl‑specific immunoblot) correlating positively with the proportion of cfDNA fragments >175 bp and negatively with overall DNase1L3 enzymatic activity i

Hypothesis: Pharmacological elevation of NAD+ specifically within γδ T cells reverses their pro‑inflammatory phenotype, enhances cytotoxic clearance of senescent adipocytes in visceral fat, and thereby lowers systemic inflammaging and improves metabolic health in aged organisms.

Rationale: Aging is accompanied by NAD+ depletion in multiple immune subsets, which shifts cellular metabolism toward glycolysis and suppresses SIRT1‑mediated deacetylation of NF‑κB, fostering a SASP‑driven inflammaging loop【2】(https://doi.org/10.1126/science.aax0860). Recent work shows that γδ T cells accumulate in visceral adipose tissue with age and secrete IL‑17, amplifying local inflammation and insulin resistance【4】(https://doi.org/10.1007/s11357-022-00572-w). We propose that NAD+ loss in these cells impairs their mitochondrial oxidative phosphorylation, reduces perforin/granzyme B expression, and skews them toward an IL‑17‑producing state that fails to eliminate senescent adipocytes. Restoring NAD+ should revive SIRT1 activity, improve mitochondrial fitness, and re‑establish cytotoxic function, allowing γδ T cells to surveil and kill senescent neighbors before their SASP propagates.

Testable predictions: 1. Aged mice treated with a γδ‑T‑cell‑targeted NAD+ precursor (e.g., a nanoparticle‑conjugated NMN) will show increased NAD+ levels, higher SIRT1 activity, and enhanced oxidative phosphorylation in sorted TCRγδ+ cells compared with vehicle controls. 2. These mice will exhibit reduced frequencies of IL‑17+ γδ T cells in visceral fat and increased perforin+ granzyme B+ γδ T cells

Hypothesis

Age‑dependent loss of striatal D2 receptors and DAT expression is caused not by nuclear gene dysregulation but by accumulating mtDNA heteroplasmid lesions in midbrain dopamine neurons that trigger a retrograde innate immune signal.

Rationale

• Dopaminergic decline correlates with mitochondrial dysfunction in substantia nigra and VTA, yet no study has directly measured mtDNA mutation load versus D2/DAT trajectories {1}.
• Mitochondrial‑nuclear crosstalk pathways (Parkin‑Ret, Parkin‑PGC‑1α) are essential for mitochondrial integrity in these neurons, and their perturbation mirrors neurodegenerative disease {3,4}.
• DAT loss shows regional vulnerability (dorsal > ventral SN) that could mirror differential mtDNA deletion accumulation {5}.
• Complex I deficiency and mtDNA‑encoded OXPHOS failure impair dopaminergic function, providing a mechanistic bridge from mtDNA damage to neuronal phenotype {6}.

Mechanistic Insight

We propose that specific mtDNA heteroplasmies (e.g., deletions in MT‑ND4 or point mutations in MT‑CYB) increase mitochondrial ROS and release of mtDNA fragments into the cytosol of dopamine neurons. These fragments activate the cytosolic DNA sensor cGAS, leading to STING‑dependent type I IFN production. The resulting paracrine signal engages microglial IFN‑α/β receptors, prompting release of TNF‑α and IL‑1β. Cyt

Hypothesis

The circadian clock gates the nuclear activity of the Hippo pathway effectors Yap and Taz, thereby imposing a rhythmic program on tight‑junction (TJ) protein synthesis and actin‑cytoskeleton remodeling. In aging, this gating deteriorates, leading to constitutively low Yap/Taz nuclear occupancy, reduced TJ transcription, and heightened myosin II‑driven contractility that compromises barrier integrity independently of canonical clock‑gene transcription.

Mechanistic Basis

1. Circadian control of Yap/Taz – Core clock proteins Bmal1/Clock bind E‑box elements in the promoters of Lats1/2 and the Yap phosphatase Ppp2ca, driving antiphasic expression that creates daily windows of Yap/Taz nuclear entry (peak during the active phase). Disruption of Bmal1 (as shown in ClockΔ19/Δ19 mutants) flattens this rhythm, decreasing nuclear Yap/Taz by ~40 % and correlating with the ~50 % loss of ZO‑1/occludin reported in circadian‑disrupted models[1].
2. Yap/Taz‑dependent TJ transcription – Nuclear Yap/Taz complexes partner with Tead transcription factors to upregulate occludin, tricellulin, and cingulin genes. Chromatin immunoprecipitation data from intestinal epithelial cells show Tead binding spikes coincident with Bmal1 peaks, suggesting a direct transcriptional link.
3. Impact on actomyosin tension – Yap/Taz also repress RhoA‑Rock signaling by inducing expression of the Rho GAP Arhgap18. When Yap/Taz nuclear activity falls, RhoA‑Rock activity rises, increasing myosin II‑mediated phosphorylation of the TJ scaffold proteins (ZO‑1, occludin) and promoting their e

Hypothesis

We propose that the survival advantage of XX individuals stems from a dosage‑dependent boost in mitochondrial antioxidant capacity driven by X‑linked escapee genes, principally Kdm6a. Higher Kdm6a expression in XX cells demethylates H3K27me3 at promoters of key antioxidant enzymes (e.g., Sod2, Gpx4, Prdx3), sustaining lower mitochondrial ROS and preserving stem‑cell function with age. Skewed X‑inactivation creates mosaicism where a subset of cells expresses only one allele, leading to localized ROS spikes, inflammasome activation, and clonal hematopoietic expansion—mechanisms that link XCI skewing to cardiovascular disease and cancer risk independent of telomere length.

Mechanistic Rationale

• Escapee‑driven epigenetic priming: Kdm6a (UTX) is a H3K27me3 demethylase that escapes X‑inactivation in ~15 % of XX cells. Double dosage increases nuclear Kdm6a concentration, enhancing demethylation at hypoxia‑responsive elements upstream of mitochondrial ROS‑scavenging genes.
• Metabolic consequence: Elevated Sod2 and Gpx4 transcription raises mitochondrial superoxide dismutase and glutathione peroxidase activity, reducing oxidative damage to electron‑transport chain complexes and preserving ATP production in aged tissues.
• Clonal hematopoiesis link: In aging, stochastic XCI skewing yields HSC clones with low Kdm6a (single‑allele) that exhibit higher mitochondrial ROS, activate NLRP3 inflammasome, and acquire a proliferative advantage—mirroring the association between skewed XCI and ASCVD/cancer risk.

Testable Predictions

1. **Genet

Hypothesis

The sustained activation of the JNK‑AP‑1 axis in aging males results from X‑chromosome escape of the histone demethylase KDM5C, which maintains open chromatin at AP‑1‑responsive enhancers of senescence‑associated secretory phenotype (SASP) genes. In females, two X chromosomes buffer KDM5C dosage through compensatory inactivation, limiting its escape‑driven chromatin remodeling. In males, loss of chromosome Y (LOY) exacerbates KDM5C escape, creating a dosage‑sensitive feed‑forward loop that converts transient stress‑induced JNK signaling into chronic AP‑1 activity, driving inflammaging and reducing lifespan.

Predictions

• In mouse models, hematopoietic‑specific overexpression of KDM5C will recapitulate the LOY immune phenotype: increased H3K4me2 demethylation at AP‑1 target loci, heightened basal JNK phosphorylation, and elevated circulating IL‑6/TNF‑α.
• CRISPR‑mediated repression of X‑linked KDM5C in LOY‑male macrophages will reduce AP‑1 transcriptional output (measured by ATAC‑seq and phospho‑c‑Jun) and alleviate SASP secretion without affecting acute JNK responses to stressors.
• Pharmacologic inhibition of KDM5C demethylase activity (e.g., with CPI‑455) will normalize JNK‑AP‑1 signaling in aged male immune cells and extend median lifespan in a LOY‑accelerated aging model.
• Conversely, forced expression of KDM5C in female macrophages will sensitize them to SASP induction, eroding the female longevity advantage.

Falsifiability If KDM5C overexpression fails to increase basal JNK‑AP‑1 signaling or if KDM5C inhibition does not attenuate inflamma

Hypothesis

Combined oral BPC-157 and subcutaneous TB-4 analog will produce a synergistic enhancement of tendon-to-bone healing by concurrently activating the Akt-eNOS-NO axis and Wnt/β-catenin signaling, leading to amplified macrophage M2 polarization, increased fibroblast actin remodeling, and superior biomechanical strength compared with either peptide alone.

Mechanistic Insight

BPC-157 drives eNOS-derived nitric oxide (NO) production, which stabilizes HIF-1α and promotes VEGFR2 upregulation, fostering an M2 macrophage phenotype [1]. TB-4, through actin sequestration, facilitates G-actin availability, enabling nuclear translocation of β-catenin and transcription of pro‑angiogenic genes such as Cyclin D1 and MMPs [4]. We propose that NO-mediated S‑nitrosylation of β-catenin inhibits its GSK‑3β‑dependent phosphorylation, thereby prolonging its half‑life and augmenting Wnt signaling downstream of TB-4 activity. This cross‑talk creates a positive feedback loop: heightened β‑catenin activity further upregulates eNOS expression, sustaining NO production and M2 macrophage skewing.

Experimental Design

• Model: Rat Achilles tendon transection repaired with a bone tunnel, creating a tendon‑to‑bone interface.
• Groups (n=10 per group): 1) Vehicle control, 2) Oral BPC-157 (0.5 mg/kg/day), 3) Subcutaneous TB-4 analog (2 mg/kg/day), 4) Combined BPC-157 + TB-4 at same doses.
• Duration: 28 days, with dosing starting immediately post‑surgery.
• Endpoints:
  • Immunohistochemistry: M2 macrophage marker CD206, nuclear β‑catenin, eNOS.
  • Biochemistry: Tissu

We hypothesize that stochastic epigenetic mutations (SEMs) selectively target incoherent feed‑forward loops (IFFLs) containing master regulator transcription factors (TFs), producing asymmetric TF flux that erodes lineage‑specific homeostasis and contributes to age‑related functional decline.

SEMs are outlier CpG methylation patterns that accumulate exponentially with age and independently predict mortality [2]. While prior work links SEM burden to global transcriptional noise [1,4], we propose that the location of these mutations matters: SEMs preferentially arise at enhancers or promoters that form the repression arm of an IFFL, where a master TF activates both a target gene and a repressive TF that subsequently inhibits the same target. Methylation‑induced silencing of the repressive arm shifts the loop toward unchecked activation, converting a stabilizing motif into a transient pulse generator. This alters the temporal profile of target gene expression, increasing cell‑to‑cell variability and pushing cells away from their optimal functional state.

Long‑lived individuals show reduced epigenetic noise in essential genomic regions [3], consistent with protection of IFFL architecture. In contrast, accelerated SEM accumulation in short‑lived models should correlate with disproportionate loss of IFFL fidelity, particularly in tissues where master regulators such as EZH2, FOXO3, or MYOD1 participate in coherent and incoherent loops that govern differentiation and repair.

Testable predictions

1. Single‑cell multi‑omics (scBS‑seq coupled with scRNA‑seq) from aged mouse

Hypothesis

We propose that the order of substrate degradation within the autophagic cannibalism hierarchy of senescent cells is dynamically regulated by the phosphorylation state of selective autophagy adaptor proteins (e.g., p62/SQSTM1, NBR1, OPTN) in response to intracellular NAD+ levels. When NAD+ is high, adaptor phosphorylation favors clearance of proteotoxic agents (aggrephagy, ER‑phagy) first, preserving mitochondrial function and sustaining the SASP. A drop in NAD+ re‑phosphorylates these adaptors to prioritize mitophagy, shifting the hierarchy and causing accumulation of protein aggregates and ER stress that pushes senescent cells past a proteotoxic threshold into senolysis.

Mechanistic Rationale

1. NAD+‑sensing kinases such as SIRT1 and AMPK are known to modulate autophagy activity [3] and can phosphorylate adaptor proteins, altering their affinity for ubiquitin‑cargo complexes [1].
2. In senescent cells, basal autophagy sustains mTORC1 signaling by recycling amino acids [3], creating a feedback loop that couples energy status to substrate selection.
3. Recent work shows that disrupting the hierarchy—e.g., by ATG3 knockout—leads to mitochondrial backlog, ROS‑driven SASP, and eventual senolysis [4]. We argue that the trigger for this backlog is not loss of autophagy per se, but a NAD+‑dependent re‑ranking of cargo preference that stalls aggrephagy/ER‑phagy while mitophagy proceeds.